Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 09/30/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 141.13% | 141.13% | 168.35% |
| Total Depreciation and Amortization | -- | -- | 96.89% | 96.89% | 128.26% |
| Total Amortization of Deferred Charges | -- | -- | 77.26% | 77.26% | 117.56% |
| Total Other Non-Cash Items | -- | -- | -159.89% | -159.88% | -179.55% |
| Change in Net Operating Assets | -- | -- | 1,704.15% | 1,698.62% | 375.70% |
| Cash from Operations | -- | -- | 49.45% | 49.45% | 25.07% |
| Capital Expenditure | -- | -- | -53.07% | -53.07% | -85.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 108.99% | 108.99% | 21.26% |
| Cash from Investing | -- | -- | 85.70% | 85.70% | 0.64% |
| Total Debt Issued | -- | -- | -43.10% | -45.46% | -18.96% |
| Total Debt Repaid | -- | -- | -84.93% | -84.93% | -17.63% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -57.21% | -57.21% | -24.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -199.78% | -199.78% | -440.54% |